News | Proton Therapy | February 25, 2016

New Maryland Proton Therapy Center Begins Treatments

Center is first in eastern U.S. to offer advanced, precise form of radiation therapy

Maryland Proton Treatment Center, MPTC, first patients treated

February 25, 2016 — The University of Maryland School of Medicine (UM SOM) announced that the Maryland Proton Treatment Center (MPTC) has treated its first cancer patients with proton therapy at a new $200 million facility.

The 110,000-square-foot center, which houses a 90-ton cyclotron, is the first in the eastern United States to offer ProBeam image guided intensity-modulated proton therapy (IMPT) — the most advanced and precise form of radiation therapy.

Unlike traditional radiation therapy, the radiation dose in proton therapy stops at the tumor site, reducing radiation dose exposure to surrounding healthy tissue. This reduces side effects and prevents damage to critical organs such as the heart, lungs, brain, spinal cord, liver, intestine, bladder or rectum. MPTC delivers the most precise form of proton therapy using a highly advanced technology called pencil beam scanning. With this technology, a proton beam precisely paints a tumor with radiation, using a pencil point beam that deposits dose layer by layer as it scans back and forth across the target area.

Proton therapy has been shown to be effective in treating a wide range of localized tumors in the brain, base of the skull, head and neck area, eye, esophagus, lung, liver, breast, spinal cord and gastrointestinal tract. It is also an important treatment option for children with cancer. Nearly 60 percent of cancer patients receive a course of radiation as part of their treatment plan, and traditional radiation is still an excellent option for most. However, of those patients, as many as 30 percent may benefit from proton therapy, according to William F. Regine, M.D., FACR, FACRO, the center’s executive director and the Isadore & Fannie Foxman Schneider Endowed Chairman and Professor of Radiation Oncology at the UM SOM.

“We are very pleased and excited to be able to make this form of radiation therapy available to cancer patients in the Baltimore-Washington region and beyond,” said Regine. “Proton therapy enables us to deliver a targeted dose of lifesaving radiation therapy directly to the tumor while minimizing radiation to healthy tissue. It can result in a more effective treatment for patients with fewer side effects. This technology is a powerful tool in our toolbox for fighting cancer.”

UM SOM and its Department of Radiation Oncology are operating and managing the new proton treatment center, which was developed in partnership with Advanced Particle Therapy LLC, based in San Diego, Calif., and Varian Medical Systems. UM SOM faculty physicians will treat patients at the new center, which is affiliated with the University of Maryland Marlene and Stewart Greenebaum Cancer Center (GCC), a National Cancer Institute-designated cancer center.

The first adult and pediatric patients undergoing treatment at MPTC have various types of cancer and will come from Maryland and around the world. Treatment can take anywhere from one session up to eight weeks, depending on the tumor. Each appointment lasts less than an hour but the actual time it takes to deliver the proton beam is only minutes. Patients can receive proton therapy in conjunction with other cancer treatment modalities such as surgery or chemotherapy.

“Our objective at MPTC is to provide patients with the most advanced medical care, tailored to the precise needs of each individual patient,” said Zeljko Vujaskovic, M.D., Ph.D., professor and head of the Division of Translational Radiation Sciences in the Department of Radiation Oncology, and director of the Maryland Proton Alliance, a new UM SOM-led organizational framework for proton therapy. “We have developed every aspect of the center with two key elements in mind: accessibility and affordability. That’s what is most important to our patients.”

Clinical research will also be a key priority of the new center, which will offer a robust clinical trial program to all its patients to further evidence-based medicine.

For more information: www.mdproton.com

Related Content

New Study Redefines Therapeutic Dose Guidelines for Non-Small Cell Lung Cancer
News | Lung Cancer | April 23, 2019
Non-small cell lung cancer is a common cancer for both men and women. Many people who are diagnosed with this type of...
Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index

Fig. 1: Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index. (Agarwal et al, Red Journal, 2019) Credit: Elsevier

News | Radiation Therapy | April 22, 2019
April 22, 2019 — A new study finds wide state
Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...
Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill. Interview with Mark Pankuch, Ph.D.

Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill.
 

Feature | April 02, 2019 | Dave Fornell, Editor and A.J. Connell
April 2, 2019 — Here is the list of the most popular content on the Imaging Technology News (ITN) magazine w
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...